DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Chaudhary NK, John RR, Boddu D, Mahasampath G, Nesadeepam N, Mathew LG.
Palonosetron is a better choice compared with ondansetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in a resource-limited pediatric oncology center: results from a randomized control trial.
J Pediatr Hematol Oncol 2019;
41 (04) 294-297
We do not assume any responsibility for the contents of the web pages of other providers.